Abstract
Two agar gel immunodiffusion (AGID) kits for the serodiagnosis of bovine leukemia virus (BLV) were imported from Europe and were compared with North American kits. The BLV AGID kits from North America and from Europe differed significantly. The punches were different, as were the pattern distribution in the agar of the reference and the test sera, resulting in differences in the reading of the immunoprecipitation lines. Based on the testing of 1200 serum samples from cattle, the European kits gave a good correlation with the American kits, as indicated by their respective kappa values. However, the European kits were found to be less sensitive when evaluated against weakly positive samples from field specimens or following a dilution trial. Only 65% and 50% of the weakly positive samples detected by the American kit #1 were detected by the European kits #2 and #3, respectively. The American kit was also capable of detecting BLV antibodies in 45% of strongly positive samples diluted 1/50 in negative sera, while antibodies were detected in only 15% of the samples with the European kit #2 and in none of the samples with the European kit #3. False negatives were also detected with the European kits. Among the false negatives, the degree of expected reactions was weak (European kit #2) or of varying degrees of positivity (European kit #3). Besides the differences in format and performance, the BLV-AGID kits in Europe are evaluated with the National Standard Serum E4 while a proficiency panel composed of a quadruplicate set of 10 reference sera is used in Canada to monitor the kits. Based on the overall observations, we noted a lack of standardization between the BLV-AGID kits used in North America and in Europe.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burridge M. J., Thurmond M. C., Miller J. M., Schmerr M. J., Van Der Maaten M. J. Fall in antibody titer to bovine leukemia virus in the periparturient period. Can J Comp Med. 1982 Jul;46(3):270–271. [PMC free article] [PubMed] [Google Scholar]
- Devare S. G., Chander S., Samagh B. S., Stephenson J. R. Evaluation of radioimmunoprecipitation for the detection of bovine leukemia virus infection in domestic cattle. J Immunol. 1977 Jul;119(1):277–282. [PubMed] [Google Scholar]
- Hoff-Jørgensen R. An international comparison of different laboratory tests for the diagnosis of bovine leukosis: suggestions for international standardization. Vet Immunol Immunopathol. 1989 Oct;22(3):293–297. doi: 10.1016/0165-2427(89)90016-0. [DOI] [PubMed] [Google Scholar]
- Meiron R., Brenner J., Gluckman A., Avraham R., Trainin Z. Humoral and cellular responses in calves experimentally infected with bovine leukemia virus (BLV). Vet Immunol Immunopathol. 1985 Jun;9(2):105–114. doi: 10.1016/0165-2427(85)90011-x. [DOI] [PubMed] [Google Scholar]
- Miller J. M., Olson C. Precipitating antibody to an internal antigen of the C-type virus associated with bovine lymphosarcoma. J Natl Cancer Inst. 1972 Nov;49(5):1459–1462. [PubMed] [Google Scholar]
- Onuma M., Olson C., Baumgartener L. E., Pearson L. D. An ether-sensitive antigen associated with bovine leukemia virus infection. J Natl Cancer Inst. 1975 Nov;55(5):1155–1158. doi: 10.1093/jnci/55.5.1155. [DOI] [PubMed] [Google Scholar]
- Pelzer K. D. Economics of bovine leukemia virus infection. Vet Clin North Am Food Anim Pract. 1997 Mar;13(1):129–141. doi: 10.1016/s0749-0720(15)30368-6. [DOI] [PubMed] [Google Scholar]